Cargando…
Plasma Osteopontin Is a Useful Diagnostic Biomarker for Advanced Non-Small Cell Lung Cancer
BACKGROUND: Osteopontin (OPN) and carbonic anhydrase IX (CAIX), which are expressed on the surface of tumor cells, are associated with hypoxia during tumor development and progression. However, the roles of these proteins in the plasma of patients with non-small cell lung cancer (NSCLC) are poorly u...
Autores principales: | Han, Seon-Sook, Lee, Seung-Joon, Kim, Woo Jin, Ryu, Dong Ryeol, Won, Jun Yeon, Park, Shinyoung, Cheon, Myeong Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790021/ https://www.ncbi.nlm.nih.gov/pubmed/24101934 http://dx.doi.org/10.4046/trd.2013.75.3.104 |
Ejemplares similares
-
Clinical Utility of Plasma Glypican-3 and Osteopontin as Biomarkers of Hepatocellular Carcinoma
por: Lee, Hyun Jung, et al.
Publicado: (2014) -
Serum Midkine and Osteopontin Levels as Diagnostic Biomarkers of Hepatocellular Carcinoma
por: Hodeib, Hossam, et al.
Publicado: (2017) -
Plasma CRABP2 as a Novel Biomarker in Patients with Non-Small Cell Lung Cancer
por: Kim, Do Jun, et al.
Publicado: (2018) -
Clinical Significance of Plasma Osteopontin Level as a Biomarker of Hepatocellular Carcinoma
por: Salem, Mona, et al.
Publicado: (2013) -
Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment
por: Chai, Yuek Ling, et al.
Publicado: (2021)